Skip to main content
Caplight Logo









Targepeutics

Targepeutics

Private
Hummelstown, PennsylvaniaHealthcare & Life Scienceshttps://targepeutics.com/

Last Round

Seed

Jul 24, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Targepeutics is a biopharmaceutical company that develops selective molecularly targeted immunotoxin therapies for the treatment of aggressive brain cancers, including glioblastoma and diffuse midline glioma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

immunotoxinglioblastomabiopharmaceuticaltargeted therapydiffuse midline gliomaDMGGBMprecision medicinebiologic therapycancer drug developmentoncologyclinical trialsdrug discoverycancer biotechbrain cancer treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Targepeutics Comparables

Compare Targepeutics with similar companies based on industry and business-model similarity.

Targepeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mesenkia Therapeutics AB
78%
MimiVax Inc.
78%
Mustang Bio Inc
77%

Targepeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 24, 2025
GrantSep 12, 2022

Key People

Founding team and executive leadership

Sil Lutkewitte

Chief Executive Officer

Executive Team

Targepeutics Investors

Notable investors and investment history

Targepeutics investors
InvestorRounds
National Cancer InstituteGrant
Yuvaan Tiwari FoundationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 40% MoM, reaching 1.7K.

  • Apr 7, 2026

    Monthly visitors increased 102% MoM.

Targepeutics Filings

Explore SEC and related filing metadata, where available.

Targepeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Targepeutics's valuation, stock price, and market status.

Is Targepeutics a public or private company?

Targepeutics is a private company.

What is the current stock price of Targepeutics?

Targepeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Targepeutics worth (valuation)?

Valuation information for Targepeutics is not publicly available.

Can I buy Targepeutics stock?

Targepeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Targepeutics's last funding round?

Funding round information for Targepeutics is not publicly available.

Who are the main investors in Targepeutics?

Investor information for Targepeutics is not publicly disclosed.

Will Targepeutics IPO soon?

No public IPO plans have been announced for Targepeutics.

How can I track Targepeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Targepeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHummelstown, Pennsylvania
Employee Range3
Year Founded2000
Last FundingJul 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?